Company news
Fennec Pharmaceuticals Inc. news in 2023
Fennec Pharmaceuticals Inc.'s news releases, calls and decks from 2023, newest first.
Fennec Announces Incremental $5 Million Investment from Petrichor
December 4, 2023
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
November 5, 2023
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023
October 29, 2023
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
August 2, 2023
Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023
July 30, 2023
Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
June 5, 2023
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
May 7, 2023
Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
March 30, 2023
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results
March 29, 2023
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
January 30, 2023
Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients
January 24, 2023
Calls in 2023
- Fennec Pharmaceuticals (NASDAQ:FENC) Q3 2023 Earnings Call
Nov 6, 2023
Transcript - Fennec Pharmaceuticals (NASDAQ:FENC) Q2 2023 Earnings Call
Aug 3, 2023
Transcript - Fennec Pharmaceuticals (NASDAQ:FENC) Q1 2023 Earnings Call
May 11, 2023
Transcript - Fennec Pharmaceuticals (NASDAQ:FENC) Q4 2022 Earnings Call
Mar 30, 2023
Transcript